Acelrx Pharmaceuticals Inc
NASDAQ:ACRX 3:59:54 PM EDT
Market Cap (Intraday) | 10.63M |
Current PE | 0.20 |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $0.96 |
50-Day MA | $0.75 |
200-Day MA | $2.41 |
Acelrx Pharmaceuticals Inc Stock, NASDAQ:ACRX
25821 Industrial Boulevard, Suite 400, Hayward, California 94545
United States of America
Phone: +1.650.216.3500
Number of Employees: 19
Description
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Hayward, CA.